Extended cell and plasma drug levels after one dose of a three-in-one nanosuspension containing lopinavir, efavirenz, and tenofovir in nonhuman primates-Reference-Cited by-同舟云学术

Extended cell and plasma drug levels after one dose of a three-in-one nanosuspension containing lopinavir, efavirenz, and tenofovir in nonhuman primates

Published:2018-11-13 Issue:17 Volume:32 Page:2463-2467
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Koehn Josefin,Iwamoto Jennifer F.,Kraft John C.,McConnachie Lisa A.,Collier Ann C.,Ho Rodney J.Y.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference26 articles.

1. Persistent HIV-1 replication maintains the tissue reservoir during therapy;Lorenzo-Redondo;Nature,2016

2. Lipid-drug association enhanced HIV-1 protease inhibitor indinavir localization in lymphoid tissues and viral load reduction: a proof of concept study in HIV-2287-infected macaques;Kinman;J Acquir Immune Defic Syndr,2003

3. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues;Fletcher;Proc Natl Acad Sci U S A,2014

4. Anti-HIV drug particles may overcome lymphatic drug insufficiency and associated HIV persistence;Freeling;Proc Natl Acad Sci U S A,2014

5. Vital signs: HIV diagnosis, care, and treatment among persons living with HIV – United States, 2011;Bradley;MMWR Morb Mortal Wkly Rep,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Combination Nanoparticles Containing Gemcitabine and Paclitaxel Enable Orthotopic 4T1 Breast Tumor Regression;Cancers;2024-08-08

2. Physiologically based Pharmacokinetic Model Validated to Enable Predictions Of Multiple Drugs in a Long-acting Drug-combination Nano-Particles (DcNP): Confirmation with 3 HIV Drugs, Lopinavir, Ritonavir, and Tenofovir in DcNP Products;Journal of Pharmaceutical Sciences;2024-06

3. Drug Nanocrystals: A Delivery Channel for Antiviral Therapies;AAPS PharmSciTech;2024-02-17

4. Long-acting parenteral drug delivery systems for the treatment of chronic diseases;Advanced Drug Delivery Reviews;2023-07

5. Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response;Pharmacology & Therapeutics;2022-08